Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Discovery
Sponsor : Medivir
Deal Size : Undisclosed
Deal Type : Partnership
Medivir and SciLifeLab Partner to Identify Covid-19 Drug Candidates
Details : The aim of the collaboration is to find potential inhibitors of the main protease of SARS CoV-2, an essential non-structural protein, Mpro, required for virus replication.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
June 07, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Discovery
Sponsor : Medivir
Deal Size : Undisclosed
Deal Type : Partnership